Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis
Open Access
- 14 January 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (1), 19-27
- https://doi.org/10.1182/bloodadvances.2019000128
Abstract
Sickle cell disease (SCD) is characterized by painful vaso-occlusive crises (VOCs). Self-reported pain intensity is often assessed with the Numeric Rating Scale (NRS), whereas newer patient-reported outcome measures (PROMs) assess multidimensional pain in SCD. We describe pain experiences among hospitalized adults with VOCs, using 2 PROMs: the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health and the Adult Sickle Cell Quality of Life Measurement System (ASCQ-Me). Adults with SCD hospitalized with VOCs at 2 academic centers in Boston, Massachusetts, from April 2016 to October 2017 were eligible. Participants completed the NRS and PROMs at admission and 7 days postdischarge. PROM scores were described and compared with population norms. Length of stay (LOS) and 30-day readmission rates were assessed. Forty-two (96%) of 44 eligible patients consented and completed admission assessments. Mean age was 30.2 years (standard deviation, 9.1), 60% were women, 76% were non-Hispanic black, and 64% had hemoglobin SS. Twenty-seven participants (64%) completed postdischarge assessments. Sixty percent had >= 4 VOCs in the last year. Nearly all PROMIS Global Health and ASCQ-Me scores were worse than population norms. NRS and PROMIS Global Physical Health scores improved after discharge, the latter driven principally by improvements in pain. Overall median LOS was 7 days, and 30-day readmission rate was 40.5%. Administration of PROMs among adults with SCD hospitalized for VOCs is feasible and demonstrates participants experienced recurrent, prolonged, and severe VOCs. PROMIS Global and ASCQ-Me scores indicated substantial suffering, and the striking 30-day readmission rate highlights the vulnerability of these patients.Keywords
This publication has 44 references indexed in Scilit:
- Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort StudyPLOS ONE, 2013
- IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesClinical Trials, 2013
- Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patientsJournal of Clinical Epidemiology, 2011
- Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better FutureClinical Pediatric Emergency Medicine, 2010
- Health‐related quality of life in adults with sickle cell disease (SCD): A report from the comprehensive sickle cell centers clinical trial consortiumAmerican Journal of Hematology, 2010
- Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)Journal of Clinical Epidemiology, 2010
- The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organizationAmerican Journal of Hematology, 2009
- Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global itemsQuality of Life Research, 2009
- Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell diseasePediatric Blood & Cancer, 2008
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008